TrialJournal of immunotherapy (Hagerstown, Md. : 1997)2015

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group.

Holly J Meany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.